Alignment Healthcare, Inc.

ALHC

Alignment Healthcare, Inc.

ALHC

Insider Sentiment (TTM):

Last Purchase:2026-06-02Last Sale:2026-06-26Shares Purchased (TTM):14,848Shares Sold (TTM):66,592,019

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:181,323,650Shares Outstanding:205,356,397Institutional Ownership Pct.:88.30%

Earnings Market Reaction:

Filing Date:2026-07-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	693	706	576	618	470	446	433	340	339	239	203	392
Assets Current
Accounts Receivable Net Current	297	278	253	220	283	214	154	139	183	165	120	106
Assets Current	1,160	1,145	952	985	880	774	662	574	599	521	484	667
Short Term Investments	8	21	28	26	34	33	38	41	25	63	116	124
Prepaid Expense And Other Assets Current	162	141	94	121	93	81	37	54	52	54	45	46
Property Plant And Equipment Net	66	64	64	67	70	69	67	65	62	57	52	47
Operating Lease Right Of Use Asset	-	-	-	-	-	-	8	8	8	9	10	10
Intangible Assets Net Including Goodwill	-	-	-	-	-	-	-	-	-	-	-	40
Goodwill	32	32	32	32	32	34	35	35	35	35	35	-
Intangible Assets Net Excluding Goodwill	5	5	5	5	5	5	5	5	5	5	5	-
Other Assets Noncurrent	8	9	6	6	6	6	6	6	7	7	6	6
Assets	1,279	1,262	1,066	1,103	1,000	896	782	692	716	633	592	771
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	32	35	33	34	31	28	22	25	23	23	24	25
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	-	146
Liabilities Current
Liabilities Current	683	725	557	611	530	457	352	358	372	331	263	410
Long Term Debt Current	-	-	-	-	-	-	-	2	-	-	-	-
Employee Related Liabilities Current	38	34	49	48	43	32	40	-	-	-	34	-
Long Term Debt Noncurrent	324	324	323	323	322	322	321	210	212	162	162	162
Operating Lease Liability Noncurrent	-	-	-	-	-	-	8	8	8	8	9	9
Liabilities	1,014	1,055	887	941	859	787	681	577	591	501	434	581
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	265	207	179	162	141	109	101	116	125	131	158	189
Additional Paid In Capital	1,226	1,204	1,188	1,160	1,143	1,125	1,108	1,092	1,074	1,058	1,037	1,021
Retained Earnings Accumulated Deficit	-961	-998	-1,009	-998	-1,002	-1,017	-1,008	-977	-951	-927	-880	-833
Minority Interest	-	-	0	0	0	1	1	1	1	1	1	1
Liabilities And Stockholders Equity	1,279	1,262	1,066	1,103	1,000	896	782	692	716	633	592	771
Allowance For Doubtful Accounts Receivable Current	0	0	1	1	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	207	207	204	200	198	198	192	-	191	191	189	189
Shares Outstanding	207	207	204	200	198	198	192	-	191	191	189	189

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-27.46%	-3.02%	-8.61%	-	-	-	-	-	-	-	-	-
2025	-13.66%	-16.76%	-26.00%	21.85%	27.23%	31.69%	-2.45%	19.28%	31.43%	-9.78%	10.41%	-18.16%
2024	36.12%	38.02%	91.44%	7.54%	32.60%	26.22%	2.90%	-9.39%	24.51%	30.73%	35.41%	17.15%
2023	-	-	-	1.90%	14.19%	22.84%	15.28%	36.22%	11.81%	-31.79%	-24.86%	4.91%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.70	1.58	1.71	1.61	1.66	1.69	1.88	1.60	1.61	1.57	1.84	1.63
Quick Ratio	1.46	1.39	1.54	1.41	1.49	1.52	1.78	1.45	1.47	1.41	1.67	1.51
Working Capital	477.04M	420.61M	394.71M	374.24M	350.60M	317.37M	309.79M	215.52M	227.57M	189.90M	220.52M	256.70M
Leverage & Debt
Debt to Equity	3.82	5.10	4.94	5.81	6.09	7.22	6.75	4.99	4.74	3.80	2.74	3.07
Interest Coverage TTM	3.39	2.24	0.93	0.14	-1.22	-2.98	-4.31	-5.14	-5.94	-6.31	-6.02	-6.72
Debt Ratio	0.79	0.84	0.83	0.85	0.86	0.88	0.87	0.83	0.83	0.79	0.73	0.75
Efficiency & Turnover
Asset Turnover TTM	4.02	3.95	4.27	4.05	3.89	3.93	3.94	3.37	2.98	2.89	2.98	2.22
Days Sales Outstanding TTM	23.12	21.08	18.82	18.00	25.50	23.05	18.47	18.07	22.25	26.32	21.28	20.56
Receivables Turnover TTM	15.79	17.31	19.40	20.28	14.31	15.84	19.76	20.20	16.40	13.87	17.15	17.76
Per Share Metrics
Diluted EPS TTM	0.19	0.09	-0.00	-0.10	-0.24	-0.47	-0.67	-0.75	-0.80	-0.83	-0.79	-0.84
Free Cash Flow Per Share TTM	0.86	1.10	0.57	0.76	0.14	0.10	-0.03	-0.98	-1.09	-1.01	-0.51	-0.25
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	-	98.93%	98.84%	98.81%
Operating Profit Margin TTM	1.20%	0.84%	0.37%	0.07%	-0.74%	-2.19%	-3.76%	-4.90%	-5.88%	-6.78%	-7.01%	-8.02%
Net Profit Margin TTM	0.89%	0.47%	-0.02%	-0.58%	-1.54%	-3.03%	-4.74%	-5.84%	-6.84%	-7.81%	-8.12%	-9.18%
Growth Metrics
Net Revenue Growth (1Y)	37.21%	41.81%	46.06%	47.39%	49.46%	49.12%	48.25%	43.47%	37.46%	31.76%	27.16%	25.49%
Net Income Growth (1Y)	-179.92%	-122.05%	-99.43%	-85.37%	-66.44%	-42.16%	-13.48%	-8.71%	-6.34%	7.57%	-1.02%	12.34%
EPS Growth (1Y)	-176.41%	-120.79%	-99.46%	-85.93%	-67.70%	-43.54%	-15.55%	-10.64%	-8.74%	4.22%	-3.68%	12.31%
Valuation Metrics
P/E TTM	120.61	180.50	-5,401.41	-164.73	-54.19	-39.66	-16.76	-15.70	-9.78	-5.96	-10.83	-8.24
P/B TTM	18.63	17.49	21.81	21.46	19.70	33.07	21.26	19.56	11.96	7.10	10.14	6.86
P/S TTM	1.08	0.85	0.99	0.95	0.83	1.20	0.79	0.92	0.67	0.47	0.88	0.76
Market Cap	4.94B	3.62B	3.91B	3.47B	2.78B	3.60B	2.15B	2.26B	1.49B	937.47M	1.60B	1.30B
Enterprise Value	4.57B	3.23B	3.66B	3.18B	2.63B	3.48B	2.03B	2.13B	1.36B	860.59M	1.56B	1.07B
Calculated Values
Free Cash Flow TTM	177.51M	226.10M	113.15M	150.56M	28.41M	19.08M	-6.65M	-186.72M	-207.19M	-190.37M	-95.18M	-46.38M
Net Debt	-371.53M	-384.10M	-254.76M	-297.44M	-150.06M	-126.42M	-113.52M	-130.70M	-129.33M	-76.87M	-43.14M	-231.80M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Konowiecki, Joseph S

Title: EVP, Corporate Affairs

Shares: 25,000

Price/Share: $23.00

Value: $575,000.00

Shares Owned: 1,128,816

Relationship: Director,Officer

Ownership: Direct

2026-06-18Sale

Owner: Konowiecki, Joseph S

Title: EVP, Corporate Affairs

Shares: 25,000

Price/Share: $22.00

Value: $550,000.00

Shares Owned: 1,153,816

Relationship: Director,Officer

Ownership: Direct

2026-06-15Sale

Owner: Maroney, Dawn Christine

Title: President

Shares: 30,000

Price/Share: $19.55

Value: $586,500.00

Shares Owned: 947,313

Relationship: Officer

Ownership: Direct

2026-06-12Sale

Owner: Kim, Hyong

Title: Chief Medical Officer

Shares: 35,951

Price/Share: $19.86

Value: $713,986.86

Shares Owned: 331,750

Relationship: Officer

Ownership: Direct

2026-06-11Sale

Owner: Konowiecki, Joseph S

Title: EVP, Corporate Affairs

Shares: 25,000

Price/Share: $21.00

Value: $525,000.00

Shares Owned: 1,178,816

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Konowiecki, Joseph S	Director,Officer	EVP, Corporate Affairs	Direct	Sale	25,000	23.00	$575,000.00	1,128,816	4
2026-06-18	Konowiecki, Joseph S	Director,Officer	EVP, Corporate Affairs	Direct	Sale	25,000	22.00	$550,000.00	1,153,816	4
2026-06-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	19.55	$586,500.00	947,313	4
2026-06-12	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	35,951	19.86	$713,986.86	331,750	4
2026-06-11	Konowiecki, Joseph S	Director,Officer	EVP, Corporate Affairs	Direct	Sale	25,000	21.00	$525,000.00	1,178,816	4
2026-06-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	298,000	20.12	$5,995,760.00	1,386,766	4
2026-06-02	Kent, Mark D.	Officer	President - MSO	Direct	Purchase	14,848	13.31	$197,626.88	14,848	4
2026-05-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	16.09	$482,700.00	998,813	4
2026-05-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	298,000	17.20	$5,125,600.00	1,508,641	4
2026-04-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	20.87	$626,100.00	1,028,813	4
2026-04-13	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	82,299	20.80	$1,711,819.20	1,806,641	4
2026-04-07	Head, James M	Officer	Chief Financial Officer	Direct	Sale	11,100	21.08	$233,988.00	173,495	4
2026-04-07	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	250,000	21.04	$5,260,000.00	2,104,641	4
2026-04-01	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	18,013	17.79	$320,451.27	305,451	4
2026-03-23	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	118,000	17.48	$2,062,640.00	2,354,641	4
2026-03-19	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	11,602	18.22	$211,388.44	148,628	4
2026-03-18	Burzacchi, Sebastian	Officer	COO - Mgmt Services Org	Direct	Sale	15,361	17.84	$274,040.24	258,630	4
2026-03-18	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	25,125	17.84	$448,230.00	323,464	4
2026-03-18	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	73,046	17.84	$1,303,140.64	1,784,868	4
2026-03-18	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	18,404	17.84	$328,327.36	367,701	4
2026-03-18	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	11,285	17.84	$201,324.40	487,685	4
2026-03-18	Maroney, Dawn Christine	Officer	President	Direct	Sale	36,749	17.84	$655,602.16	1,058,813	4
2026-03-16	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	17.48	$524,400.00	1,095,562	4
2026-03-12	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	4,044	17.24	$69,718.56	498,970	4
2026-03-12	Maroney, Dawn Christine	Officer	President	Direct	Sale	29,113	17.24	$501,908.12	963,702	4
2026-03-12	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	48,899	17.24	$843,018.76	1,519,480	4
2026-03-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	18.19	$3,274,200.00	2,472,641	4
2026-03-04	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	21,118	18.62	$393,217.16	148,687	4
2026-02-17	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	20.63	$618,900.00	997,015	4
2026-02-10	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	22,238	20.47	$455,211.86	169,805	4
2026-02-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	20.49	$3,688,200.00	2,652,641	4
2026-01-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	22.48	$674,400.00	1,027,015	4
2026-01-12	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	21.34	$3,841,200.00	2,832,641	4
2026-01-06	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	16,506	21.35	$352,403.10	333,133	4
2026-01-06	Maroney, Dawn Christine	Officer	President	Direct	Sale	228,152	21.33	$4,866,482.16	1,057,015	4
2026-01-02	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	10,611	20.03	$212,538.33	297,088	4
2025-12-29	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	605,648	19.05	$11,537,594.40	2,234,294	4
2025-12-29	Maroney, Dawn Christine	Officer	President	Direct	Sale	282,070	19.05	$5,373,433.50	1,385,167	4
2025-12-29	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	69,541	19.05	$1,324,756.05	503,014	4
2025-12-29	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	12,694	19.05	$241,820.70	349,639	4
2025-12-29	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	16,187	19.05	$308,362.35	307,699	4
2025-12-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	113,319	20.01	$2,267,513.19	1,667,237	4
2025-12-12	General, Atlantic Genpar,…	TenPercentOwner	-	Indirect	Sale	11,119,494	18.57	$206,489,003.58	13,476,585	4
2025-12-12	General, Atlantic (Aln Hl…	TenPercentOwner	-	Indirect	Sale	11,119,494	18.57	$206,489,003.58	13,476,585	4
2025-12-10	Burzacchi, Sebastian	Officer	COO - Mgmt Services Org	Direct	Sale	12,585	19.26	$242,387.10	237,793	4
2025-12-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	19.02	$3,423,600.00	2,346,726	4
2025-12-08	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	19,706	19.33	$380,916.98	323,886	4
2025-11-25	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	19.00	$475,000.00	1,056,141	4
2025-11-11	Konowiecki, Joseph S	Director	-	Direct	Sale	4,832	16.49	$79,679.68	1,081,141	4
2025-11-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	16.32	$2,937,600.00	2,526,726	4
2025-10-28	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	18.00	$450,000.00	1,085,973	4
2025-10-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	17.29	$3,112,200.00	2,706,726	4
2025-10-09	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	51,379	17.57	$902,729.03	362,333	4
2025-09-17	General, Atlantic Partner…	Director,TenPercentOwner	-	Indirect	Sale	6,246,096	16.01	$99,999,996.96	24,596,079	4
2025-09-17	General, Atlantic (Aln Hl…	Director,TenPercentOwner	-	Indirect	Sale	6,246,096	16.01	$99,999,996.96	24,596,079	4
2025-09-16	Konowiecki, Joseph S	Director	-	Direct	Sale	16,076	16.24	$261,074.24	1,110,973	4
2025-09-12	Gap, Coinvestments Cda, L…	Director,TenPercentOwner	-	Indirect	Sale	13,460,000	16.01	$215,494,600.00	30,842,175	4
2025-09-12	General, Atlantic (Aln Hl…	Director,TenPercentOwner	-	Indirect	Sale	13,460,000	16.01	$215,494,600.00	30,842,175	4
2025-09-10	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	355,018	16.55	$5,875,547.90	4,533,568	4
2025-09-10	Maroney, Dawn Christine	Officer	President	Direct	Sale	215,662	16.50	$3,558,423.00	1,797,237	4
2025-09-10	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	29,535	16.55	$488,804.25	572,555	4
2025-09-10	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	30,939	16.55	$512,040.45	343,592	4
2025-09-09	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	17.00	$425,000.00	1,127,049	4
2025-08-25	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	12,032	16.47	$198,167.04	192,043	4
2025-08-22	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	24,800	16.00	$396,800.00	447,367	4
2025-08-13	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	14.90	$447,000.00	2,012,899	4
2025-08-13	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	18,600	15.03	$279,558.00	472,167	4
2025-08-11	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	18,600	14.54	$270,444.00	490,767	4
2025-08-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	14.60	$2,628,000.00	1,373,100	4
2025-07-31	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	15,491	16.01	$248,010.91	374,531	4
2025-07-31	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	16.00	$400,000.00	1,152,049	4
2025-07-14	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	13.44	$403,200.00	2,042,899	4
2025-07-10	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	180,000	13.41	$2,413,800.00	1,553,100	4
2025-06-16	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	14.48	$434,400.00	2,072,899	4
2025-06-16	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	14.48	$1,303,200.00	1,733,100	4
2025-06-11	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	19,399	15.26	$296,028.74	204,075	4
2025-06-11	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	40,863	15.20	$621,117.60	602,090	4
2025-06-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	15.27	$1,374,300.00	1,823,100	4
2025-05-19	General, Atlantic (Aln Hl…	Director,TenPercentOwner	-	Indirect	Sale	17,000,000	15.28	$259,760,000.00	44,302,175	4
2025-05-19	General, Atlantic Partner…	Director,TenPercentOwner	-	Indirect	Sale	17,000,000	15.28	$259,760,000.00	44,302,175	4
2025-05-14	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	14.95	$448,500.00	2,102,899	4
2025-05-12	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	14.84	$1,335,600.00	1,913,100	4
2025-05-01	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	25,000	16.87	$421,750.00	390,022	4
2025-04-14	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	19.10	$1,719,000.00	2,003,100	4
2025-04-14	Maroney, Dawn Christine	Officer	President	Direct	Sale	230,000	19.10	$4,393,000.00	2,132,899	4
2025-04-01	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	25,000	18.47	$461,750.00	415,022	4
2025-03-27	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	34,430	17.89	$615,952.70	4,923,186	4
2025-03-27	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	7,225	17.89	$129,255.25	678,987	4
2025-03-27	Maroney, Dawn Christine	Officer	President	Direct	Sale	11,152	17.89	$199,509.28	2,362,899	4
2025-03-27	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	2,864	17.89	$51,236.96	702,953	4
2025-03-27	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	6,744	17.89	$120,650.16	1,464,419	4
2025-03-20	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	26,734	17.22	$460,359.48	509,367	4
2025-03-19	Burzacchi, Sebastian	Officer	COO - Mgmt Services Org	Direct	Sale	6,694	16.52	$110,584.88	250,378	4
2025-03-19	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	11,432	16.52	$188,856.64	1,471,163	4
2025-03-19	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	8,266	16.52	$136,554.32	536,101	4
2025-03-19	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	34,101	16.52	$563,348.52	4,957,616	4
2025-03-19	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	7,234	16.52	$119,505.68	705,817	4
2025-03-19	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	7,632	16.52	$126,080.64	223,474	4
2025-03-19	Maroney, Dawn Christine	Officer	President	Direct	Sale	16,535	16.52	$273,158.20	2,374,051	4
2025-03-19	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	11,016	16.52	$181,984.32	440,022	4
2025-03-19	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	6,602	16.52	$109,065.04	686,212	4
2025-03-17	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	15.99	$479,700.00	2,417,700	4
2025-03-12	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	5,313	15.58	$82,776.54	668,106	4
2025-03-12	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	14,692	15.58	$228,901.36	1,402,862	4
2025-03-12	Maroney, Dawn Christine	Officer	President	Direct	Sale	27,243	15.58	$424,445.94	2,276,732	4
2025-03-12	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	53,122	15.58	$827,640.76	4,680,542	4
2025-03-12	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	4,856	15.58	$75,656.48	678,137	4
2025-03-07	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	21,574	15.35	$331,160.90	486,302	4
2025-03-06	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	10,871	15.53	$168,826.63	386,974	4
2025-03-06	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	55,403	15.53	$860,408.59	673,419	4
2025-03-06	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	218,295	15.53	$3,390,121.35	1,417,554	4
2025-03-06	Maroney, Dawn Christine	Officer	President	Direct	Sale	278,917	15.53	$4,331,581.01	2,303,975	4
2025-03-06	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	7,626	15.53	$118,431.78	507,876	4
2025-03-06	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Sale	554,713	15.53	$8,614,692.89	4,733,664	4
2025-03-06	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	86,659	15.53	$1,345,814.27	682,993	4
2025-02-18	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	13.72	$411,600.00	1,576,097	4
2025-02-12	Wagner, Andreas P.	Officer	Chief Human Resources Officer	Direct	Sale	14,878	14.38	$213,945.64	200,885	4
2025-02-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	14.23	$1,280,700.00	2,183,100	4
2025-01-24	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	14,500	14.98	$217,210.00	295,444	4
2025-01-21	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	10,500	14.99	$157,395.00	309,944	4
2025-01-15	Maroney, Dawn Christine	Officer	President	Direct	Sale	30,000	13.61	$408,300.00	1,606,097	4
2025-01-13	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	13.11	$1,179,900.00	2,273,100	4
2024-12-16	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	30,000	11.33	$339,900.00	1,636,097	4
2024-12-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	11.65	$1,048,500.00	2,363,100	4
2024-12-10	Burzacchi, Sebastian	Officer	COO - Mgmt Services Org	Direct	Sale	8,550	11.26	$96,273.00	217,395	4
2024-12-05	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	62,574	12.20	$763,402.80	470,496	4
2024-11-27	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	35,000	12.80	$448,000.00	320,444	4
2024-11-15	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	30,000	11.35	$340,500.00	1,696,097	4
2024-11-11	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	13.42	$1,207,800.00	2,453,100	4
2024-11-11	Konowiecki, Joseph S	Director	-	Direct	Sale	6,920	13.73	$95,011.60	1,134,888	4
2024-11-11	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	30,500	13.42	$409,310.00	92,929	4
2024-11-04	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	20,500	13.06	$267,730.00	355,444	4
2024-10-31	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	36,197	12.04	$435,811.88	123,429	4
2024-10-15	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	30,000	10.77	$323,100.00	1,726,097	4
2024-10-14	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	30,500	11.50	$350,750.00	164,109	4
2024-10-09	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	11.33	$1,019,700.00	2,543,100	4
2024-10-08	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	39,320	12.04	$473,412.80	194,609	4
2024-10-08	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	22,460	11.03	$247,733.80	533,070	4
2024-10-02	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	9,125	11.01	$100,466.25	233,929	4
2024-10-01	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	667	11.79	$7,863.93	364,445	4
2024-09-17	Konowiecki, Joseph S	Director	-	Direct	Sale	16,413	11.77	$193,181.01	1,141,808	4
2024-09-16	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	30,000	11.70	$351,000.00	1,756,097	4
2024-09-16	Kao, John E	Director,Officer	Chief Executive Officer	Indirect	Sale	90,000	11.70	$1,053,000.00	2,633,100	4
2024-09-13	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	14,500	12.00	$174,000.00	264,429	4
2024-09-13	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	12.00	$300,000.00	1,158,221	4
2024-09-12	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	25,000	11.48	$287,000.00	380,444	4
2024-09-11	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	34,626	9.73	$336,910.98	365,112	4
2024-09-05	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	4,541	10.00	$45,410.00	399,738	4
2024-09-05	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	4,789	10.00	$47,890.00	407,990	4
2024-08-23	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	2,926	9.06	$26,509.56	1,786,097	4
2024-08-15	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	20,000	8.70	$174,000.00	1,796,097	4
2024-08-14	Margolis, Jeffrey H	Director	-	Indirect	Sale	1,200	8.83	$10,596.00	413,533	4
2024-08-02	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	1,333	9.00	$11,997.00	405,579	4
2024-07-19	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	36,700	10.01	$367,367.00	1,816,097	4
2024-07-19	Freeman, Robert Thomas	Officer	Chief Financial Officer	Indirect	Sale	38,858	10.01	$388,968.58	414,429	4
2024-07-17	Konowiecki, Joseph S	Director	-	Direct	Sale	25,000	10.00	$250,000.00	1,208,221	4
2024-07-16	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	25,000	9.98	$249,500.00	405,444	4
2024-07-15	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	15,034	9.05	$136,057.70	406,912	4
2024-07-15	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	39,700	9.04	$358,888.00	1,916,097	4
2024-07-15	Konowiecki, Joseph S	Director,Officer	Chairman of the Board	Direct	Sale	22,400	9.06	$202,944.00	1,233,221	4
2024-07-15	Margolis, Jeffrey H	Director	-	Indirect	Sale	1,200	8.94	$10,728.00	414,733	4
2024-07-01	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	666	8.00	$5,328.00	422,246	4
2024-06-14	Margolis, Jeffrey H	Director	-	Indirect	Sale	1,200	8.06	$9,672.00	415,933	4
2024-06-14	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	16,000	8.01	$128,160.00	422,912	4
2024-06-12	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	20,000	8.21	$164,200.00	1,956,097	4
2024-03-28	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	10,151	4.84	$49,130.84	1,976,097	4
2024-03-28	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	1,821	4.84	$8,813.64	436,822	4
2024-03-28	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	4,299	4.84	$20,807.16	865,407	4
2024-03-28	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	4,363	4.84	$21,116.92	430,444	4
2024-03-20	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	13,252	4.83	$64,007.16	1,986,248	4
2024-03-19	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	3,078	5.05	$15,543.90	438,643	4
2024-03-19	Kim, Hyong	Officer	Chief Medical Officer	Direct	Sale	5,576	5.05	$28,158.80	555,530	4
2024-03-19	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	28,522	5.05	$144,036.10	869,706	4
2024-03-19	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	18,964	5.05	$95,768.20	434,807	4
2024-03-19	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	25,060	5.05	$126,553.00	438,912	4
2024-03-15	Kardes, Hakan	Officer	Chief Experience Officer	Direct	Sale	4,326	4.89	$21,154.14	453,771	4
2024-03-15	Scavo, Robert L.	Officer	Chief Information Officer	Direct	Sale	4,852	4.89	$23,726.28	441,721	4
2024-03-15	Freeman, Robert Thomas	Officer	Chief Financial Officer	Direct	Sale	11,858	4.89	$57,985.62	898,228	4
2024-03-15	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	21,537	4.89	$105,315.93	2,015,361	4
2024-03-14	Kao, John E	Director,Officer	Chief Executive Officer	Direct	Purchase	103,000	4.82	$496,460.00	2,745,253	4
2024-03-08	Maroney, Dawn Christine	Officer	President, Markets	Direct	Sale	23,000	5.44	$125,120.00	1,830,008	4
2023-12-14	Margolis, Jeffrey H	Director	-	Indirect	Sale	1,200	8.46	$10,152.00	417,133	4
2023-12-06	Margolis, Jeffrey H	Director	-	Indirect	Sale	1,200	8.00	$9,600.00	418,333	4
2023-11-10	Konowiecki, Joseph S	Director,Officer	Chairman of the Board	Direct	Sale	4,898	5.90	$28,898.20	1,188,221	4
2023-10-16	Margolis, Jeffrey H	Director	-	Indirect	Sale	6,000	8.00	$48,000.00	419,533	4
2023-09-13	Joyce, Christopher J	Officer	Chief Legal and Admin. Officer	Direct	Sale	15,474	5.20	$80,464.80	267,834	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

88.30%

Inst. Shares: 181,323,650

Shares Outstanding: 205,356,397

2025-12-31

87.07%

Inst. Shares: 172,405,671

Shares Outstanding: 198,006,216

2025-09-30

82.67%

Inst. Shares: 164,541,110

Shares Outstanding: 199,026,808

2025-06-30

85.52%

Inst. Shares: 169,616,648

Shares Outstanding: 198,328,613

2025-03-31

86.51%

Inst. Shares: 167,492,610

Shares Outstanding: 193,606,438

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	181,323,650	205,356,397	88.30%
2025-12-31	172,405,671	198,006,216	87.07%
2025-09-30	164,541,110	199,026,808	82.67%
2025-06-30	169,616,648	198,328,613	85.52%
2025-03-31	167,492,610	193,606,438	86.51%
2024-12-31	164,543,983	190,793,552	86.24%
2024-09-30	158,549,881	191,361,283	82.85%
2024-06-30	159,249,984	190,891,787	83.42%
2024-03-31	153,094,340	189,005,394	81.00%
2023-12-31	147,290,052	186,214,784	79.10%
2023-09-30	145,309,573	187,328,318	77.57%
2023-06-30	145,575,166	185,991,460	78.27%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Alignment Healthcare, Inc. (ALHC) — SEC Financial Statements & Analysis

Alignment Healthcare, Inc. (ALHC) is a hospital & medical service plans company, incorporated in DE. Alignment Healthcare, Inc. trades on Nasdaq as: ALHC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Alignment Healthcare, Inc. reported a 37.21% year-over-year revenue growth, a Gross Profit Margin of 98.93% (TTM), a Debt-to-Equity ratio of 3.82x, a Price-to-Sales (P/S) ratio of 1.08x (TTM), a Price-to-Book (P/B) ratio of 18.63x (TTM), at a market cap of $4.94B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 37.21%
Gross Profit Margin TTM: 98.93%
Debt To Equity: 3.82x
P/S TTM: 1.08x
P/B TTM: 18.63x
Market Cap: $4.94B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Alignment Healthcare, Inc. in?

Alignment Healthcare, Inc. (ALHC) operates in the Hospital & Medical Service Plans industry.

What is ALHC's market cap?

Alignment Healthcare, Inc. (ALHC) has a market capitalization of $4.94B as of 2026-06-30.

What is ALHC's P/E ratio?

Alignment Healthcare, Inc. (ALHC)'s trailing twelve month P/E ratio is 120.61x as of 2026-06-30.

What exchange does ALHC trade on?

Alignment Healthcare, Inc. (ALHC) trades on the Nasdaq.

Where is Alignment Healthcare, Inc. incorporated?

Alignment Healthcare, Inc. is incorporated in DE.